All In Biotech

Drug Trial Radar · NCT06208657

Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer

Last checked: Nov 19, 2026Latest source record: Jan 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

90

Planned (sponsor's estimate)

Start

Jul 10, 2024

Primary completion

Dec 2030

Study completion Dec 2035

Sponsor

Sponsor type
Academic, hospital or other
Collaborators
The Hospital for Sick Children; Medical Research Future Fund; Kazia Therapeutics Limited; C17 Council; Bristol-Myers Squibb; Stand Up To Cancer
First posted
Jan 17, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 0 years, up to 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A companion platform trial to test novel targeted agents based on the patient's tumor profile.

Conditions

  • Childhood Cancer
  • Childhood Solid Tumor
  • Childhood Brain Tumor
  • Recurrent Cancer
  • Refractory Cancer

Interventions

  • PaxalisibDrug

    Paxalisib starting at 21mg/m2 oral, daily, 28 day cycle, 13 cycles.

  • OpdualagDrug

    Opdualag, a fixed-dose combination of Nivolumab 480mg and Relatlimab 160mg, intravenous, on day 1, 28 day cycle, 26 cycles

  • Irinotecan (drug)Drug

    Irinotecan starting at 50mg/m2/day, intravenous, on days 1-5, 28 day cycle, 13 cycles.

  • Temozolomide (TMZ)Drug

    Temozolomide starting at 150mg/m2/day, oral, on days 1-5, 28 day cycle, 13 cycles.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants treated with molecularly-targeted agents in each treatment arm.Time frame: 5 Years
  2. Recommended phase II dose for each treatment armTime frame: 3 Years
  3. Objective Response Rate (ORR) for each treatment arm.Time frame: 5 Years

Locations

14 sites in 2 countries. Site status is shown where the registry gives one.

  • John Hunter Children's Hospital

    Newcastle, New South Wales, Australia · Recruiting

  • Sydney Children's Hospital, Randwick

    Sydney, New South Wales, Australia · Recruiting

  • The Children's Hospital at Westmead

    Sydney, New South Wales, Australia · Recruiting

  • Queensland Children's Hospital

    Brisbane, Queensland, Australia · Recruiting

  • Women's and Children's Hospital

    Adelaide, South Australia, Australia · Recruiting

  • Royal Hobart Hospital

    Hobart, Tasmania, Australia · Recruiting

  • Monash Children's Hospital

    Melbourne, Victoria, Australia · Recruiting

  • The Royal Children's Hospital

    Melbourne, Victoria, Australia · Recruiting

  • Perth Children's Hospital

    Perth, Western Australia, Australia · Recruiting

  • Stollery Children's Hospital

    Edmonton, Canada · Not yet recruiting

  • CHU Sainte Justine

    Montreal, Canada · Recruiting

  • Children's Hospital of Eastern Ontario

    Ottawa, Canada · Not yet recruiting

  • The Hospital for Sick Children

    Toronto, Canada · Recruiting

  • BC Children's Hospital

    Vancouver, Canada · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.